U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904416) titled 'Clinical Study to Evaluate the Performance of the INSTI(R) HCV Antibody Test for CLIA-Waived Use' on Oct. 22.
Brief Summary: multicenter prospective study to evaluate the clinical performance, usability and contrived result interpretation of the INSTI(R) HCV Antibody Test (INSTI HCV) with fingerstick (FS) whole blood specimens from participants with signs or symptoms of hepatitis or participants at risk for hepatitis C infection, by untrained operators at CLIA Waived settings.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
HCV Infection
Intervention:
DIAGNOSTIC_TEST: INSTI HCV Antibody Test
The INSTI(R) HCV A...